← Leaderboards
Robert C. Rizzo
State University New York Stony Brook
$7,144,550
Attributed
$10,949,304
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,949,304 · 7
By mechanism
R01$7,274,310 · 4
R35$2,789,423 · 1
R21$885,571 · 2
Top collaborators
- Iwao Ojima6 shared
- Martin Kaczocha5 shared
- Lloyd C Trotman5 shared
- Carol A Carter2 shared
- Amy Lynn Jacobs2 shared
- Michael Virgil Airola1 shared
- Maurizio Del Poeta1 shared
- Matthew D Scharff1 shared
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Carlos Simmerling$6,133,512
- Carol A Carter$8,806,806
- Iwao Ojima$7,814,090
- Michael Virgil Airola$3,835,845
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureDesignProteinsDockingProgramsBaseLeadMolecularInhibitor/AntagonistScreeningValidationAnalogBiologicalSiteSmall MoleculeResistanceAffinityViralMethodologyLigandsPharmaceutical PreparationsComputer AssistedInnovationLibraries
Grant awards (28)
Developing new antifungals against sterolglycosidases$782,178
R01 · FY2025 · AI
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$426,294
R35 · FY2025 · GM · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$629,362
R01 · FY2024 · CA
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$426,294
R35 · FY2024 · GM · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$654,000
R01 · FY2023 · CA
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$658,627
R01 · FY2022 · CA
A combined computational and experimental approach to the evolution and role of the DNA sequence environment in targeting mutations to antibody V regions$578,750
R01 · FY2022 · AI
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$387,367
R35 · FY2022 · GM · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$676,650
R01 · FY2021 · CA
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$387,367
R35 · FY2021 · GM · contact PI
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer$695,974
R01 · FY2020 · CA
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$387,367
R35 · FY2020 · GM · contact PI
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$387,367
R35 · FY2019 · GM · contact PI
Targeting Tsg101 to Identify Inhibitors of HIV-1 Budding by Experimental, Computational and Virtual Screening$236,016
R21 · FY2019 · AI
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design$387,367
R35 · FY2018 · GM · contact PI
Targeting Tsg101 to Identify Inhibitors of HIV-1 Budding by Experimental, Computational and Virtual Screening$197,758
R21 · FY2018 · AI
Structure-based Design of Zika Virus Inhibitors Targeting Envelope Glycoprotein (E)$199,089
R21 · FY2017 · AI · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$296,508
R01 · FY2016 · GM · contact PI
Structure-based Design of Zika Virus Inhibitors Targeting Envelope Glycoprotein (E)$252,708
R21 · FY2016 · AI · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$296,508
R01 · FY2015 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$296,508
R01 · FY2014 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$50,000
R01 · FY2014 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$295,743
R01 · FY2013 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$270,798
R01 · FY2012 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$270,798
R01 · FY2011 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$273,115
R01 · FY2010 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$274,607
R01 · FY2009 · GM · contact PI
Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41$274,184
R01 · FY2008 · GM · contact PI